Wells Pharma of Houston LLC 2026-05-06 Health serious FDA
Health · FDA · Recall #FDA-D-0506-2026
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per… Recall
Issued May 6, 2026 · Wells Pharma of Houston LLC
In May 2026, Wells Pharma of Houston LLC recalled the fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
cGMP deviations.
What you should do
- 1 Stop using fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Wells Pharma of Houston LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Wells Pharma of Houston LLC
- Category
- Health
- Recall date
- May 6, 2026
- Units affected
- Not reported
- Sold at
- U.S. Nationwide.
- Recall number
- FDA-D-0506-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- Wells Pharma of Houston LLC has 4 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 356th Health recall we've logged in 2026.